Few places have a longer association with copper than Cyprus. The Mediterranean island has produced the metal for thousands of years, supplying ancient civilisations and establishing a mining tradition so
Few places have a longer association with copper than Cyprus. The Mediterranean island has produced the metal for thousands of years, supplying ancient civilisations and establishing a mining tradition so
StockBoxMedia catches up with Mike Whitlow, Co-Founder and Executive Director of Axies Ventures (AIM: AXV), at the London Stock Exchange following the company’s admission to AIM on 4 November 2026.
Forgent PLC (AIM: FORG) has disclosed an increase in the shareholding of investor Mike Whitlow, who has raised his direct voting interest in the company from 6.50% to 8.19%.
Axies Ventures (AIM: AXV), the copper and gold exploration and development company with operations in Cyprus and Canada, is pleased to announce the launch of an interactive investor website to
Update on exploration programmes following AIM Admission Petalas drilling, Kokkinoantonis dump development work being advanced and Canadian assay results anticipated
StockBox speaks to Jason Germiquet, Managing Director of newly AIM-listed Axies Ventures, for an introduction to the company, its exploration portfolio and the opportunities ahead.
Axies Ventures (AIM: AXV) has commenced trading on London’s AIM market, marking a new chapter for the copper and gold exploration company as it advances its flagship Kokkinoantonis Complex in
With a flagship Cyprus discovery, a sizeable opportunity in historic mine dumps and an emerging Ontario copper trend, Axies Ventures is preparing to bring a portfolio of high-potential exploration assets
Mendell Helium (LON: MDH) has welcomed the US Department of Energy’s decision to designate helium as a critical material, highlighting its existing US production operations and plans to expand output
Mendell Helium (LON: MDH) has identified five prospective production well locations at its Fort Dodge project in Kansas, United States, following detailed seismic analysis, with its fully funded 2026 drilling
Physiomics plc (AIM: PYC) has secured a new £102,000 drug development modelling contract, taking the total value of contract awards announced since May 2026 to more than £970,000, exceeding the
Physiomics plc (AIM: PYC) has secured a new £119,000 contract for drug development modelling while exploring additional commercial opportunities for its personalised dosing technology, including potential expansion into the US